EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Haemodynamic Effects of Sodium–Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients

C Noah Nilsson, Mads Kristian Ersbøll, Finn Gustafsson

Cardiac Failure Review · 11.09.2024 · 10

DOI: 10.15420/cfr.2023.25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 11.09.2024. Verfasst von C Noah Nilsson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital Rigshospitalet Denmark. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium–glucose cotransporter 2 inhibitors (SGLT-2i) are now recommended in the current European Society of Cardiology/American College of Cardiology guidelines for the treatment of heart failure (HF) across the spectrum of left ventricular ejection fraction (LVEF) and several large trials have documented the beneficial effects of this drug class on cardiovascular outcomes. Although the clinical efficacy of SGLT-2 inhibition in HF is now well recognised, research is still ongoing to better understand the underlying mechanistic effects of this drug class. In this paper we assess the haemodynamic effects following SGLT-2i treatment in HF patients by reviewing the current literature. We focus our review on preload of the LV in terms of filling pressure and pulmonary artery pressure, cardiac output and afterload. We discuss these variables stratified according to HF with reduced LVEF (HFrEF) and HF with preserved LVEF (HFpEF). Finally, we examine the evidence of LV remodelling in the setting of SGLT-2i-related changes in haemodynamics.

Schlagwörter

Stichwörter der Autor:innen

Heart failureSGLT-2 inhibitorcardiac remodellinghaemodynamic

Autor:innen und Institutionen

  • Department of Cardiology, Copenhagen University Hospital Rigshospitalet Denmark.

Zitieren

APA

Nilsson, C. N., Ersbøll, M. K., & Gustafsson, F. (2024). Haemodynamic Effects of Sodium–Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients. Cardiac Failure Review, 10. https://doi.org/10.15420/cfr.2023.25

Vancouver

Nilsson CN, Ersbøll MK, Gustafsson F. Haemodynamic Effects of Sodium–Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients. Cardiac Failure Review. 2024;10. doi:10.15420/cfr.2023.25

BibTeX
@article{Nilsson2024,
  author = {Nilsson, C Noah and Ersbøll, Mads Kristian and Gustafsson, Finn},
  title = {Haemodynamic Effects of Sodium–Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients},
  journal = {Cardiac Failure Review},
  year = {2024},
  volume = {10},
  doi = {10.15420/cfr.2023.25}
}
Kostenlos starten →